| Piramal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543635 |
NSE Symbol : PPLPHARMA |
P/E(TTM) : 29.28 |
|
ISIN Demat : INE0DK501011 |
Div & Yield% : 0.09 |
EPS(TTM) : 5.55 |
|
Book Value(₹) : 58.28 |
Market Cap(₹Cr) : 21,600.28 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 5,285.71 | 4,390.11 | 3,443.22 | 3,340.42 | 2,938.81 |
| Other Income | 207.35 | 202.06 | 341.07 | 224.79 | 216.20 |
| Stock Adjustments | 84.57 | 61.62 | -53.31 | 32.66 | -57.86 |
| Total Income | 5,577.63 | 4,653.79 | 3,730.98 | 3,597.87 | 3,097.15 |
| EXPENDITURE : | |||||
| Raw Materials | 2,330.53 | 2,170.46 | 1,715.17 | 1,594.17 | 1,169.91 |
| Power and Fuel Cost | 131.62 | 112.89 | 107.94 | 83.83 | 68.08 |
| Other Manufacturing Expenses | 284.35 | 251.57 | 259.29 | 299.83 | 252.74 |
| Selling and Administration Expenses | 746.69 | 620.04 | 485.63 | 427.82 | 258.75 |
| Miscellaneous Expenses | 100.46 | 64.92 | 182.81 | 59.20 | 117.39 |
| Employee Benefit Expenses | 736.19 | 613.93 | 548.50 | 448.03 | 395.15 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,247.79 | 819.98 | 431.64 | 684.99 | 835.13 |
| Interest | 114.56 | 107.10 | 115.87 | 57.29 | 4.71 |
| Gross Profit | 1,133.23 | 712.88 | 315.77 | 627.70 | 830.42 |
| Depreciation | 222.09 | 205.26 | 192.08 | 165.37 | 143.64 |
| Profit Before Tax | 911.14 | 507.62 | 123.69 | 462.33 | 686.78 |
| Current Tax | 199.44 | 112.48 | 38.77 | 110.82 | 104.98 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 20.30 | 3.92 | 15.42 | -16.03 | 10.30 |
| Reported Net Profit | 691.40 | 391.22 | 69.50 | 367.54 | 571.50 |
| Extraordinary Items | 1.24 | 3.34 | -3.14 | -10.64 | 15.44 |
| Adjusted Net Profit | 690.16 | 387.88 | 72.64 | 378.18 | 556.06 |
| Adjustment below Net Profit | 1.05 | -3.79 | -2.59 | 31.70 | -2.46 |
| Profit/Loss Balance carried down | 1,359.23 | 971.79 | 918.28 | 569.04 | 0.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 14.47 | 0.00 | 13.40 | 50.00 | 0.00 |
| P & L Balance carried down | 2,037.21 | 1,359.22 | 971.79 | 918.28 | 569.04 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1.40 | 1.10 | 0.00 | 5.60 | 0.00 |
| Dividend Per Share(Rs) | 0.14 | 0.11 | 0.00 | 0.56 | 0.00 |
| Earnings Per Share-Unit Curr | 5.22 | 2.96 | 0.58 | 3.10 | 5.75 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 56.27 | 50.74 | 44.09 | 43.20 | 41.23 |
| Book Value(Adj)-Unit Curr | 56.27 | 50.74 | 43.06 | - | - |